retatrutide 2025 trial results 28.7% Weight Loss in New Study – Dr Brad Stanfield CutKilo | Retatrutide - what

In the TRIUMPH-1 Phase 3 trial, participants on the 12 mg dose lost an average of 28.3% of their body weight at 80 weeks, and up to 30.3% at 104 weeks in the study extension

Certain bacterial strains stimulate L-cells to produce more GLP-1 naturally

Shipping and Risk of Loss See our Shipping Policy for full details

Ivm Health is not affiliated with, endorsed by, or sponsored by these manufacturers.

Clinical trials show that orforglipron can help people lose, on average, about 12% of their body weight

But to do this, you first need to figure out your total daily energy expenditure (TDEE), aka the total number of calories your body burns daily to maintain your current weight